Global Human Immune Globulin Intravenous Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Human Immune Globulin Intravenous market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Human Immune Globulin Intravenous market.
Major Players in the Human Immune Globulin Intravenous market are:
Grifols, S.A.
Octapharma AG
Pfizer, Inc.
ADMA Biologics, Inc.
Takeda Pharmaceutical Company Limited
LFB Biotechnologies S.A.S
Kedrion Biopharma, Inc.
CSL Behring
Bio Products Laboratory Ltd.
Biotest AG
McKesson Corporation
On the basis of types, the Human Immune Globulin Intravenous market is primarily split into:
IVIg Liquid
IVIg Powder
On the basis of applications, the market covers:
Out-patient
In-patient
Home
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Human Immune Globulin Intravenous Market Overview
- 1.1 Product Overview and Scope of Human Immune Globulin Intravenous Market
- 1.2 Human Immune Globulin Intravenous Market Segment by Type
- 1.2.1 Global Human Immune Globulin Intravenous Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Human Immune Globulin Intravenous Market Segment by Application
- 1.3.1 Human Immune Globulin Intravenous Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Human Immune Globulin Intravenous Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Human Immune Globulin Intravenous (2017-2029)
- 1.5.1 Global Human Immune Globulin Intravenous Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Human Immune Globulin Intravenous Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Human Immune Globulin Intravenous Industry
- 1.7 Impact of Carbon Neutrality on the Human Immune Globulin Intravenous Industry
- 2 Human Immune Globulin Intravenous Market Upstream and Downstream Analysis
- 2.1 Human Immune Globulin Intravenous Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Human Immune Globulin Intravenous Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Grifols, S.A.
- 3.1.1 Grifols, S.A. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Octapharma AG
- 3.2.1 Octapharma AG Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Pfizer, Inc.
- 3.3.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 ADMA Biologics, Inc.
- 3.4.1 ADMA Biologics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Takeda Pharmaceutical Company Limited
- 3.5.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 LFB Biotechnologies S.A.S
- 3.6.1 LFB Biotechnologies S.A.S Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Kedrion Biopharma, Inc.
- 3.7.1 Kedrion Biopharma, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 CSL Behring
- 3.8.1 CSL Behring Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Bio Products Laboratory Ltd.
- 3.9.1 Bio Products Laboratory Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Biotest AG
- 3.10.1 Biotest AG Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 McKesson Corporation
- 3.11.1 McKesson Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Human Immune Globulin Intravenous Market Performance (2017-2022)
- 3.11.4 Business Overview
- 4 Global Human Immune Globulin Intravenous Market Landscape by Player
- 4.1 Global Human Immune Globulin Intravenous Sales and Share by Player (2017-2022)
- 4.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Player (2017-2022)
- 4.3 Global Human Immune Globulin Intravenous Average Price by Player (2017-2022)
- 4.4 Global Human Immune Globulin Intravenous Gross Margin by Player (2017-2022)
- 4.5 Human Immune Globulin Intravenous Market Competitive Situation and Trends
- 4.5.1 Human Immune Globulin Intravenous Market Concentration Rate
- 4.5.2 Human Immune Globulin Intravenous Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Human Immune Globulin Intravenous Sales, Revenue, Price Trend by Type
- 5.1 Global Human Immune Globulin Intravenous Sales and Market Share by Type (2017-2022)
- 5.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Type (2017-2022)
- 5.3 Global Human Immune Globulin Intravenous Price by Type (2017-2022)
- 5.4 Global Human Immune Globulin Intravenous Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Human Immune Globulin Intravenous Sales, Revenue and Growth Rate of IVIg Liquid (2017-2022)
- 5.4.2 Global Human Immune Globulin Intravenous Sales, Revenue and Growth Rate of IVIg Powder (2017-2022)
- 6 Global Human Immune Globulin Intravenous Market Analysis by Application
- 6.1 Global Human Immune Globulin Intravenous Consumption and Market Share by Application (2017-2022)
- 6.2 Global Human Immune Globulin Intravenous Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Human Immune Globulin Intravenous Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Human Immune Globulin Intravenous Consumption and Growth Rate of Out-patient (2017-2022)
- 6.3.2 Global Human Immune Globulin Intravenous Consumption and Growth Rate of In-patient (2017-2022)
- 6.3.3 Global Human Immune Globulin Intravenous Consumption and Growth Rate of Home (2017-2022)
- 6.3.4 Global Human Immune Globulin Intravenous Consumption and Growth Rate of Others (2017-2022)
- 7 Global Human Immune Globulin Intravenous Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Human Immune Globulin Intravenous Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Human Immune Globulin Intravenous Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Human Immune Globulin Intravenous Market Forecast (2022-2029)
- 8.1 Global Human Immune Globulin Intravenous Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Human Immune Globulin Intravenous Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Human Immune Globulin Intravenous Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Human Immune Globulin Intravenous Price and Trend Forecast (2022-2029)
- 8.2 Global Human Immune Globulin Intravenous Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Human Immune Globulin Intravenous Sales and Revenue Forecast (2022-2029)
- 8.3 Global Human Immune Globulin Intravenous Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Human Immune Globulin Intravenous Revenue and Growth Rate of IVIg Liquid (2022-2029)
- 8.3.2 Global Human Immune Globulin Intravenous Revenue and Growth Rate of IVIg Powder (2022-2029)
- 8.4 Global Human Immune Globulin Intravenous Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Human Immune Globulin Intravenous Consumption Value and Growth Rate of Out-patient (2022-2029)
- 8.4.2 Global Human Immune Globulin Intravenous Consumption Value and Growth Rate of In-patient (2022-2029)
- 8.4.3 Global Human Immune Globulin Intravenous Consumption Value and Growth Rate of Home (2022-2029)
- 8.4.4 Global Human Immune Globulin Intravenous Consumption Value and Growth Rate of Others (2022-2029)
- 8.5 Human Immune Globulin Intravenous Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Human Immune Globulin Intravenous Market Drivers Analysis
- 9.2 Human Immune Globulin Intravenous Market Restraints and Challenges
- 9.3 Human Immune Globulin Intravenous Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Human Immune Globulin Intravenous Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Human Immune Globulin Intravenous Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Human Immune Globulin Intravenous Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook